Charles J. Homcy, Chairman of Pharmaceuticals at BridgeBio Pharma, Inc. (BBIO), sold 180,314 shares at $37.50 ($6.7M) on 2020-09-29, disclosed to the SEC on 2020-09-29.
Open-market sale of $6.7M BBIO by Chairman of Pharmaceuticals. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.68 | 65,661 | $2.4M | 36.2% |
| 2 | $36.68 | 65,661 | $2.4M | 36.2% |
| 3 | $37.47 | 15,396 | $577K | 8.7% |
| 4 | $37.47 | 15,396 | $577K | 8.7% |
| 5 | $37.50 | 18,200 | $683K | 10.3% |
| Total | $36.90 avg | 180,314 |
| $6.7M |
| 100% |
| Filing → |
| BBIO | SELL | 2020-10-01 | $380K | — | Filing → |
| BBIO | SELL | 2020-02-12 | $720K | — | Filing → |
| BBIO | SELL | 2020-01-16 | $350K | — | Filing → |